Navigation Links
BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
Date:5/20/2008

NOVATO, Calif., May 20 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) today announced that the first patient has initiated treatment in the Phase 1 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU). The study is expected to conclude enrollment in the fourth quarter of 2008.

"We are dedicated to serving the PKU community and hope to address the entire spectrum of PKU patients between PEG-PAL and Kuvan. We believe PEG-PAL holds tremendous potential to bring blood Phe down to normal levels and may help patients who either do not respond to Kuvan or who wish to reduce blood Phe levels beyond what is possible with Kuvan," said Jean-Jacques Bienaime, Chief Executive Officer of BioMarin. "Positive preclinical data shows sustained decreases in blood Phe levels in PKU mice without any notable safety concerns and we hope to see the same results in humans."

The Phase 1 clinical trial is an open-label, multi-center study to be conducted in approximately 35 PKU patients in a series of seven dose- escalating cohorts ranging from 0.001 to 1.0 mg/kg, with each cohort receiving a single dose, and a 6-week follow-up period.

The primary objective of the study is to assess the safety and tolerability of single, subcutaneous injections of PEG-PAL in subjects with PKU. The secondary objectives of the study are to evaluate the pharmacokinetics of single, subcutaneous injections of PEG-PAL administered at escalating doses and to evaluate the effect of PEG-PAL on blood Phe concentrations in subjects with PKU.

About PEG-PAL

PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) is an investigational enzyme substitution therapy for the treatment of PKU. Pharmacology studies conducted in the PKU mouse model demonstrated that weekly subcutaneous administrations of PEG-PAL resulted in a significant and stable decrease of plasma phenylalanine. BioMar
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. BioMarin Announces FDA Approval for Kuvan
2. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
3. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
4. ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354
5. Go Healthy Initiates Additional Clinical Tests on Cholesterade
6. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
7. Proteolix Initiates Phase 2 Clinical Trial of Carfilzomib in Patients With Relapsed Solid Tumors
8. Cara Therapeutics Initiates Phase 1 Clinical Trial of Novel Analgesic, CR845
9. Agennix Initiates A Randomized Double-Blind, Placebo-Controlled Phase 2 Study of Oral Talactoferrin in Severe Sepsis
10. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
11. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/z9s8mp/laboratory ) has ... - Global Strategic Business Report" report to ... are provided for the period 2014 through 2020. ... these markets. Market data and analytics are derived ... primarily based on public domain information including company ...
(Date:6/2/2015)... BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) ... Mark A. Sirgo , President and Chief Executive Officer ... Jefferies 2015 Global Healthcare Conference Tuesday, June 2 ... York City , NY The presentation will ... .  For those who are not available to listen to ...
(Date:6/2/2015)... Fla. , June 2, 2015  One hundred ... of Science in Nurse Anesthesia (MSNA) graduates of April ... their first attempt. The graduating class was composed of ... 2015.  The NCE is required of ... Nurse Anesthetist, and graduates of the MSNA program are ...
Breaking Medicine Technology:Laboratory Centrifuges - Global Strategic Business Report 2014-2020: Developed Markets Slowdown, While Emerging Markets Surge 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference - Schedule Change 3ADU's Master of Science in Nurse Anesthesia April 2015 Graduates Earn 100 Percent First Time Pass Rate on National Certification Examination 2
... , DURHAM, N.C., Sept. 8 ... formally notified Vatea Fund of the company,s achievement of a milestone ... September 1, 2009. The milestone is a Clinical Trial for Oxycyte ... With the achievement of the milestone, the agreement calls for ...
... BOZEMAN, Mont., Sept 8 LigoCyte Pharmaceuticals, Inc. ... clinical trial of its norovirus vaccine. The Phase I/II ... nasally-delivered, dry powder vaccine in healthy adults. The study will ... by including a live virus challenge of subjects that have ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 2LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 3
(Date:6/2/2015)... On Wednesday, May 27, 2015, professional driver, ... top speed of 207.9 mph. In the process, Hennessey’s ... the 200 mph mark. Jay Leno was on hand ... of Jay Leno’s Garage, which will air on CNBC later ... mile high speed oval at the Continental Tire Proving Grounds ...
(Date:6/2/2015)... Milwaukee, WI (PRWEB) June 02, 2015 ... to announce Lauren Potter from the hit show Glee ... Down Syndrome Awareness Walk in Pleasant Prairie, WI. The ... services for families in Racine, Kenosha, and Walworth counties. ... to have Lauren join us for this important event," ...
(Date:6/2/2015)... Island, N.Y. (PRWEB) June 02, 2015 ... refer to computer generated imagery overlaid on the real ... gone but Vein Visualization, which displays a map of ... shown a steady growth in adoption. , AccuVein, the ... 40% year over year growth rate and such widespread ...
(Date:6/2/2015)... Ahmedabad, Gujarat, India (PRWEB) June 02, 2015 ... a finalist in the 2015 Microsoft Worldwide Small and ... a global field of top Microsoft partners for demonstrating ... on Microsoft technology. , “This comes as no ... expertise are recognized third year consecutively at worldwide level ...
(Date:6/2/2015)... 2015 Did you wish Ryder Weise a ... him, his family isn’t asking for presents, but instead a ... in Saturday’s Cure HHT DC Walk. , Ryder was diagnosed ... malformed blood vessels leading to sudden and extreme bleeding throughout ... Ryder was 3 years old in the form of daily ...
Breaking Medicine News(10 mins):Health News:774 HP Hennessey Mustang Tested to 207.9 mph 2Health News:Glee star Lauren Potter helps Down Syndrome Association of WI raise awareness, support 2Health News:Vein Visualization Emerges as Premier Augmented Reality Application 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 2Health News:Bitscape Infotech recognized as finalist for 2015 Microsoft Worldwide small & midsized cloud solutions award. 3Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2
... for couples lasts from 3 to 13 minutes, contrary ... sexual activity, according to a survey of U.S. and ... and Jenay Guardiani conducted a survey of 50 full ... which include psychologists, physicians, social workers, marriage/family therapists and ...
... By Will Arnett, Matthew Broderick, Steve Carell, Stephen, ... Kevin James,Conan O,Brien, Rosie O,Donnell, Amy Poehler, Adam Sandler, ... The Insult Comic Dog And Many More To Be ... announced today that,Kelsey Grammer, Ben Stiller, Grammy Award-winning band ...
... points to possible weapon against human infection with deadly ... have successfully tested several Ebola vaccines in monkeys and ... for one of the world,s deadliest diseases. , ... We are seeing more and more naturally occurring human ...
... , Montreal, March 31, 2008 A team of ... for a significant fraction of ALS (sporadic amyotrophic lateral sclerosis) ... an incurable neuromuscular disorder that affects motor neurons and leads ... Published in the current online edition of Nature Genetics, the ...
... Md., March 31 The Epilepsy,Foundation,s quick reaction to ... forums raises awareness of the need for Web security ... -- and those who,use its online forums for help, ... who posted rapidly flashing images to cause,serious injury and ...
... first to use a new tool to identify the molecular ... what these microscopic signatures or biomarkers should look like. , ... of Proteome Research, the advance could one day lead to ... as well as other diseases. , With many diseases, the ...
Cached Medicine News:Health News:Good sexual intercourse lasts minutes, not hours, therapists say 2Health News:Kelsey Grammer, Ben Stiller, Maroon 5 and The Roots Added to COMEDY CENTRAL's(R) Live On-air Charity Special 'Night of Too Many Stars: An Overbooked Concert for Autism Education' Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET 2Health News:Researchers Successfully Test Ebola Vaccines 2Health News:Researchers identify a gene responsible for cases of Lou Gehrig's disease 2Health News:Epilepsy Foundation Takes Action Against Hackers 2Health News:Scientists: New technique identifies molecular 'biomarkers' for disease 2Health News:Scientists: New technique identifies molecular 'biomarkers' for disease 3
The PC2200h contains two shelves and will hold two PF96hi agitators. It can store 192 random bags (64 apheresis bags)....
The PC3200i has three shelves and will hold three PF96i agitators. Total capacity is 288 random bags (96 apheresis bags)....
... rotators and agitators for continual ... set at 22C (71F) or ... (59F to 104F). Uniformity is ... bottom. Recorder is standard on ...
... incubators hold rotators and agitators ... can be set at 22C ... to 40C (59F to 104F). ... top to bottom. Recorder is ...
Medicine Products: